Vantaxa is NOT indicated for depression or anxiety
Based on the FDA drug label, Vantaxa is a topical analgesic indicated only for temporary relief of minor muscle and joint aches due to backache, arthritis, strains, bruises, and sprains 1. It is for external use only and has no psychiatric indications whatsoever 1.
Critical Clarification
You may be confusing Vantaxa with vortioxetine (brand name Trintellix/Brintellix), which is an entirely different medication. Vortioxetine is an FDA-approved antidepressant with the following indications:
Vortioxetine's Actual Indications
Depression (Major Depressive Disorder):
- Vortioxetine is FDA-approved specifically for major depressive disorder (MDD) in adults 2
- Effective at doses of 5-20 mg/day, with higher doses (20 mg) showing greater efficacy 3
- Works through multimodal serotonergic action (SERT inhibition plus modulation of 5-HT3, 5-HT7, 5-HT1D, 5-HT1B, and 5-HT1A receptors) 2, 4
Anxiety (as comorbid condition, not primary indication):
- Not FDA-approved for generalized anxiety disorder (GAD) as a standalone indication 2
- However, demonstrates significant anxiolytic effects in patients with MDD and comorbid anxiety 5
- In patients with severe MDD and severe comorbid GAD, vortioxetine 20 mg/day achieved 55% HAM-A response and 42% remission rates at 8 weeks 5
- 52% of patients achieved response on both depression and anxiety scales simultaneously 5
Clinical Bottom Line
- Vantaxa = topical pain relief only
- Vortioxetine = antidepressant for MDD, with beneficial effects on comorbid anxiety but not approved as monotherapy for primary anxiety disorders
If treating depression with comorbid anxiety, vortioxetine represents an evidence-based choice, particularly when cognitive dysfunction or emotional blunting are present 6, 4. Start at 10 mg/day with forced up-titration to 20 mg/day after one week for optimal efficacy in severe presentations 5.